Stories by Sydney Lupkin

Sydney Lupkin

Pharmaceuticals Correspondent

Restrictions on obesity drug coverage force patients to pivot
By Sydney Lupkin

Restrictions on obesity drug coverage force patients to pivot

Sydney Lupkin | Apr 22, 2026, 1:25 PM UTC
Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.